Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00220_DB01558_nanopub.RA9gQKCLYuS4GRDBpqJHypkmqIF_8LXiZgWUl7VjjXOhA#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00220_DB01558 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00220_DB01558 label "DDI between Nelfinavir and Bromazepam - Nelfinavir, a strong CYP3A4 inhibitor, may increase the serum concentration of bromazepam by decreasing its metabolism. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of bromazepam if nelfinavir is initiated, discontinued or dose changed. Dosage adjustments may be required. [drugbank_resource:DB00220_DB01558]" assertion.
- drugbank_resource:DB00220_DB01558 identifier "drugbank_resource:DB00220_DB01558" assertion.
- drugbank_resource:DB00220_DB01558 title "DDI between Nelfinavir and Bromazepam - Nelfinavir, a strong CYP3A4 inhibitor, may increase the serum concentration of bromazepam by decreasing its metabolism. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of bromazepam if nelfinavir is initiated, discontinued or dose changed. Dosage adjustments may be required." assertion.
- drugbank:DB00220 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00220_DB01558 assertion.
- drugbank:DB01558 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00220_DB01558 assertion.